Boothbay Fund Management, LLC Alnylam Pharmaceuticals, Inc. Put Options Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $1.9 Million - $2.58 Million	13,000 Added 53.28%	37,400 $5.59 Million
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $3.69 Million - $4.8 Million	24,400 New	24,400 $4.67 Million
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $1.1 Million - $1.54 Million	-9,100 Reduced 65.94%	4,700 $686,000
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $2.58 Million - $3.53 Million	-20,300 Reduced 59.53%	13,800 $2.25 Million
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $4.39 Million - $6.03 Million	34,100 New	34,100 $5.78 Million

584

104M

2.82M

1.75M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.